COMMUNIQUÉS West-GlobeNewswire

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

24/04/2024 - 15:00

LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensitive 4th generation [...]

Verana Health Announces Launch of Qdata® Thyroid Eye Disease

24/04/2024 - 15:00

Expansive real-world dataset, comprising more than 250,000 de-identified patients, will help advance research and expedite therapy development for thyroid eye disease SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- [...]

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

24/04/2024 - 15:00

LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report [...]

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

24/04/2024 - 15:00

Live webcast on Wednesday, May 1 st at 3:20 PM ET THE WOODLANDS, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on [...]

Canadians Come Together to Make Positive Impact During Multiple Sclerosis Awareness Month This May

24/04/2024 - 15:00

MS Canada welcomes people across the nation to support the MS community by participating in its signature initiatives as they work toward a world free from MS TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- May is Multiple [...]

Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting

24/04/2024 - 15:00

More than 25 Doheny Scientists Selected to Give Talks and Present Papers and Posters; Director of Artificial Intelligence & Imaging Research SriniVas R. Sadda, MD, to Step Into Role as ARVO President PASADENA, Calif [...]

Novo Nordisk A/S - Articles of Association, April 2024

24/04/2024 - 14:57

Novo Nordisk's Articles of Association, April 2024 Attachment Articles of Association 24 Apr 2024

Novo Nordisk A/S – Reduction of the share capital

24/04/2024 - 14:48

Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by cancellation of part of the [...]

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

24/04/2024 - 14:47

Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of [...]

United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism

24/04/2024 - 14:30

COPENHAGEN, Denmark, April 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing [...]

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

24/04/2024 - 14:30

CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its first- [...]

Smart for Life Appoints Prominent Industry Executive David Trosin to Company’s Advisory Board

24/04/2024 - 14:30

Managing Director of Health Sciences Certification at NSF International Joins Highly Diversified Team of Advisors at Smart for Life MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart [...]

BriaCell Announces Oral and Poster Presentations at ASCO 2024

24/04/2024 - 14:00

Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MD Two poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and Cristofanilli (Weill Cornell [...]

BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange

24/04/2024 - 14:00

Strategic Audit Completion Set to Enhance BioStem Technologies' Market Position and Shareholder Value POMPANO BEACH, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative [...]

Scilex Holding Company Announces $15 Million Registered Direct Offering

24/04/2024 - 14:00

PALO ALTO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase

24/04/2024 - 14:00

CHATHAM, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, [...]

LifeMD to Report First Quarter 2024 Financial Results on May 8

24/04/2024 - 14:00

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 [...]

Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer

24/04/2024 - 14:00

Dr. Goncalves, former CMO at Cara Therapeutics, joins Oruka as CMO Eugenia Levi, PharmD, former Head of Global Medical Affairs for Cosentyx at Novartis, also joins as VP, Medical Affairs WALTHAM, Mass., April 24, 2024 ( [...]

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

24/04/2024 - 13:05

First non-immunosuppressive therapy for the treatment of IgA nephropathy (IgAN) approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaningful results from the [...]